Sitagliptin and Exenatide(type 2 diabetes drugs) causes pancreatitis and pancreatic cancer.

<![CDATA[

Patients who are using the type 2 diabetes medications sitagliptin and exenatide appear more likely to report pancreatitis and pancreatic cancer, a new study has found. The retrospective study, which analyzed a US Food and Drug Administration (FDA) reporting system, also found a possible association of thyroid cancer with the use of exenatide.

These results were presented September 14 at the European Association for the Study of Diabetes (EASD) 47th Annual Meeting. The study, by Michael Elashoff, from the Larry L. Hillblom Islet Research Center, University of California, Los Angeles, and colleagues, was published in the July issue of *Gastroenterology*.

“[Our analysis] suggests that the [glucagon-like peptide 1 (GLP-1)] class of drugs being widely promoted for treatment of type 2 diabetes could have serious unintended and unpredicted side effects,” the authors write.

Ref and Read more: http://www.medscape.com/viewarticle/750284?sssdmh=dm1.720622&src=nldne

]]>